1. Home
  2. OCS vs MTAL Comparison

OCS vs MTAL Comparison

Compare OCS & MTAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCS
  • MTAL
  • Stock Information
  • Founded
  • OCS 2003
  • MTAL 2021
  • Country
  • OCS Switzerland
  • MTAL Jersey
  • Employees
  • OCS N/A
  • MTAL N/A
  • Industry
  • OCS Biotechnology: Pharmaceutical Preparations
  • MTAL Blank Checks
  • Sector
  • OCS Health Care
  • MTAL Finance
  • Exchange
  • OCS Nasdaq
  • MTAL Nasdaq
  • Market Cap
  • OCS 689.8M
  • MTAL 690.2M
  • IPO Year
  • OCS N/A
  • MTAL 2021
  • Fundamental
  • Price
  • OCS $19.45
  • MTAL $12.16
  • Analyst Decision
  • OCS Strong Buy
  • MTAL Hold
  • Analyst Count
  • OCS 4
  • MTAL 2
  • Target Price
  • OCS $31.50
  • MTAL $14.00
  • AVG Volume (30 Days)
  • OCS 29.0K
  • MTAL 634.7K
  • Earning Date
  • OCS 05-08-2025
  • MTAL 04-29-2025
  • Dividend Yield
  • OCS N/A
  • MTAL N/A
  • EPS Growth
  • OCS N/A
  • MTAL N/A
  • EPS
  • OCS N/A
  • MTAL N/A
  • Revenue
  • OCS $847,333.00
  • MTAL $340,736,000.00
  • Revenue This Year
  • OCS $53.79
  • MTAL $21.07
  • Revenue Next Year
  • OCS $1,860.95
  • MTAL $19.84
  • P/E Ratio
  • OCS N/A
  • MTAL N/A
  • Revenue Growth
  • OCS N/A
  • MTAL 114.30
  • 52 Week Low
  • OCS $10.79
  • MTAL $7.69
  • 52 Week High
  • OCS $23.08
  • MTAL $14.93
  • Technical
  • Relative Strength Index (RSI)
  • OCS 58.76
  • MTAL 75.84
  • Support Level
  • OCS $17.33
  • MTAL $9.88
  • Resistance Level
  • OCS $20.45
  • MTAL $12.48
  • Average True Range (ATR)
  • OCS 0.80
  • MTAL 0.29
  • MACD
  • OCS 0.19
  • MTAL 0.28
  • Stochastic Oscillator
  • OCS 68.75
  • MTAL 80.49

About OCS Oculis Holding AG Ordinary shares

Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.

About MTAL Metals Acquisition Limited

MAC Copper Ltd is a company focused on operating and acquiring metals and mining businesses in high-quality, stable jurisdictions that are critical in the electrification and decarbonization of the world-wide economy.

Share on Social Networks: